CClinicalTrials.gg
CompletedNCT03402269Updated Mar 28, 2023

Treatment of Pediatric Mid-shaft Clavicle Fractures: A Prospective, Observational Study

An observational study in Clavicle Fracture and Adolescent, sponsored by Prisma Health-Upstate. Completed at 1 site in United States. Open to participants aged 11 Years to 17 Years. Per ClinicalTrials.gov, last updated 2023-03-28.

Sponsored by Prisma Health-Upstate · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
30
Ages
11 Years to 17 Years
Sex
All
01

Study summary

Clavicle fractures in children are common. Typical treatment includes nonoperative treatment with a sling. Operative treatment is usually limited to open, unstable, fractures with either epidermal risks or neurovascular compromise. Orthopaedic literature has many studies that report the need for additional research for this prevalent fracture. This is an observational study evaluating the functional and patient reported outcomes of displaced clavicle fractures in adolescents. The results from this study will help the orthopedist understand the expected outcomes for a given pediatric patient with a clavicle fracture.

02

Conditions studied

  • Clavicle Fracture
  • Adolescent

Browse trials for

03

Who can participate

Ages eligible
11 Years to 17 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

11-17 years old with displaced fractures of the middle third of the clavicle

Inclusion criteria

  • 11-17 years old with fractures of the middle third of the clavicle
  • Displaced 100% the width of the clavicle or shortened 1 centimeter
  • Operative and non-operative treated clavicles will be eligible for enrollment

Exclusion criteria

Exclusion Criteria:

  • Open clavicle fractures
  • Ipsilateral shoulder injuries
  • Fractures involving the lateral ligaments or the sternoclavicular joint
  • Bilateral clavicle fractures
  • Pathologic fractures
  • Refractures
  • Fractures with neurovascular compromise
  • Displaced fractures with impending skin compromise
  • If there has been more than 21 days between injury and enrollment
  • Patients with cognitive disabilities that inhibit the completion of the questionnaires
04

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
30 participants (actual)
Patient registry
No

Groups and cohorts

  • Adolescents with displaced clavicle fractures

    Adolescents (11 to 17 years old) with displaced clavicle fractures will be enrolled in this study.

    Other: Clavicle fracture injury- observation

Interventions

  • OtherClavicle fracture injury- observation

    The study is an observational study with assessments at 1 month, 3 months, 6 months and 1 year following injury. Assessments include range of motion, strength, patient reported outcomes and radiographic healing

05

What researchers measure

Primary outcomes

  1. Range of motion

    Range of motion measured by goniometer

    Time frame: at 1 year post injury

  2. Radiographic healing

    Radiographic evidence of healing on 3 of 4 cortices

    Time frame: at 1 year post injury

Secondary outcomes

  1. QuickDash

    QuickDash Outcome Measure- measuring patient reported disability of arm, shoulder and hand

    Time frame: at 3 months, 6 months and 12 months

  2. PODCI

    Adolescent Pediatric Outcomes Data Collection Instrument - measuring patient reported outcomes in a pediatric population

    Time frame: at 3 months, 6 months and 12 months

Other outcomes

  1. Strength Measurements

    Upper extremity strength measurements, measured by dynamometer (forward flexion, abduction, and external rotation

    Time frame: 6 months and 12 months

06

Study locations

1 site
  • Greenville Hospital System
    Greenville, South Carolina 29605, United States
07

References and documents

Study documents

  • Informed consent form · Feb 11, 2019

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No — There are no plans to share IPD

08

Registry details

Key details

Study ID
NCT03402269
Lead sponsor
Prisma Health-Upstate
Responsible party
Sponsor
First posted
Jan 18, 2018
Start date
Jan 10, 2018
Primary completion
Dec 31, 2020
Completion
Dec 31, 2022
Last update
Mar 28, 2023

Study contacts

Christopher C Bray, MD
principal investigator · Prisma Health-Upstate

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion